Significantly modified metabolic and endocrine features can be found in PCOS patients by using insulin-sensitizing drugs, which may demonstrate that insulin resistance plays an important role in the etiology of PCOS (Holte et al., 1995; Azziz et al., 2001; Barber et al., 2006). The gene discussed is INS; the disease is polycystic ovary syndrome.